Trial record 1 of 1 for: Study C38072/3084
Previous Study | Return to List | Next Study
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
This study has been completed.
Teva Branded Pharmaceutical Products, R&D Inc.
First Posted: January 12, 2012
Last Update Posted: June 27, 2016
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )